Literature DB >> 24900067

Endometrial Cancer with Cervical Extension Mimicking Dual Concordant Endometrial and Cervical Malignancy by F-18 FDG PET and MRI.

Seok-Nam Yoon1.   

Abstract

Entities:  

Year:  2012        PMID： 24900067      PMCID： PMC4043034          DOI： 10.1007/s13139-012-0139-7

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN： 1869-3474


× No keyword cloud information.
  6 in total

1.  The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer.

Authors:  Keiichiro Nakamura; Atsushi Hongo; Junichi Kodama; Yuji Hiramatsu
Journal:  Gynecol Oncol       Date:  2011-07-20       Impact factor: 5.482

Review 2.  Established, emerging and future applications of FDG-PET/CT in the uterine cancer.

Authors:  K Kitajima; K Murakami; Y Kaji; S Sakamoto; K Sugimura
Journal:  Clin Radiol       Date:  2011-01-14       Impact factor: 2.350

3.  The SUVmax of 18F-FDG PET correlates with histological grade in endometrial cancer.

Authors:  Keiichiro Nakamura; Junichi Kodama; Yoshihiro Okumura; Atsushi Hongo; Susumu Kanazawa; Yuji Hiramatsu
Journal:  Int J Gynecol Cancer       Date:  2010-01       Impact factor: 3.437

4.  Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.

Authors:  Mauro Signorelli; Luca Guerra; Alessandro Buda; Maria Picchio; Giorgia Mangili; Tiziana Dell'Anna; Sandro Sironi; Cristina Messa
Journal:  Gynecol Oncol       Date:  2009-08-19       Impact factor: 5.482

5.  F-18 FDG PET Images of the Cervix at Various Time Points after the Loop Electrosurgical Excision Procedure.

Authors:  Shin Young Jeong; Jung-Joon Min
Journal:  Nucl Med Mol Imaging       Date:  2010-02-26

6.  High-grade endometrial cancer: value of [(18)F]FDG PET/CT in preoperative staging.

Authors:  Maria Picchio; Giorgia Mangili; Ana M Samanes Gajate; Patrizia De Marzi; Elena G Spinapolice; Paola Mapelli; Giampiero Giovacchini; Cristina Sigismondi; Riccardo Viganò; Sandro Sironi; Cristina Messa
Journal:  Nucl Med Commun       Date:  2010-06       Impact factor: 1.690
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.